9 Results for "

sirt7+activator

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "sirt7+activator" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-158162
Target:  

Sirtuin

Research Areas:  

Cardiovascular Disease

SIRT3 activator 1 (Compound 5v) is a SIRT3 activator. SIRT3 activator 1 selectively elevates SIRT3 expression, leading to the upregulation of SOD2 and OPA1 expression, effectively preventing mitochondrial dysfunction, mitigating oxidative stress, and preserving cardiomyocyte viability. SIRT3 activator 1 can be used for research of cardiovascular diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-163987
CAS No.: 3061491-60-6
Target:  

Sirtuin

Research Areas:  

Neurological Disease

SIRT3 activator 2 (compound 2a) is a SIRT3 activator. SIRT3 activator 2 improved the thermal stability of SIRT3 in SH-SY5Y cells, indicating that it can directly bind to SIRT3, has SIRT3 dependency in SH-SY5Y to clear α-Syn. SIRT3 activator 2 improves motor function in Parkinson mice, preventing Parkinson (DA) neuron loss in the substantia nigra in a dose-dependent manner .
loading...
    loading...
Cat. No.: HY-148712
CAS No.: 2601734-99-8
Purity:  98.01%
Target:  

Apoptosis Sirtuin

Research Areas:  

Cancer

SIRT6 activator 12q is potent, selective and orally active SIRT6 activator with IC50 values of 171.20, >200, >200, >200, 0.58 μM for SIRT1, SIRT2, SIRT3, SIRT5, SIRT6, respectively. SIRT6 activator 12q inhibits cell growth and migration. SIRT6 activator 12q induces Apoptosis and cell cycle arrest at G2 phase. SIRT6 activator 12q shows anticancer activity .
loading...
    loading...
Cat. No.: HY-111317
CAS No.: 839699-72-8
Target:  

Sirtuin

Research Areas:  

Metabolic Disease

SIRT1 activator 3 is a potent activator of Sirt1 and suppresses TNF-α in a dose-dependent manner. SIRT1 activator 3 has the potential for anti-obesity or anti-diabetic researches .
loading...
    loading...
Cat. No.: HY-156023
CAS No.: 863589-52-0
Purity:  99.28%
SIRT1 activator 2 is a SIRT1 activator with an ED50 value <5 μM. SIRT1 activator 2 modulates SIRT1 deacetylase activity. SIRT1 activator 2 can be used for aging research .
loading...
    loading...
Cat. No.: HY-169159
CAS No.: 2867630-96-2
Target:  

Sirtuin

Research Areas:  

Metabolic Disease

SIRT6 activator 2 (compound 31) is a sirtuin 6 activator with anti-lipid accumulation properties. SIRT6 activator 2 significantly downregulates LXR, SREBP-1c, and their target genes associated with lipogenesis, and can be used for research related to lipid metabolism-related diseases .
loading...
    loading...
Cat. No.: HY-N12386
SIRT1 activator 1(compound 3) is a derivative of marine compound xyloallenoide A isolated from the mangrove fungus Xylaria sp.SIRT1 activator 1 shows angiogenic activities in zebrafish. SIRT1 activator 1 protects hEPC against AngII-induced senescence by increasing SIRT1 expression levels and balancing the AMPK/Akt signaling pathway .
loading...
    loading...
Cat. No.: HY-182061
Target:  

Sirtuin

Research Areas:  

Cancer

SIRT6 activator 3 (Compound 24) is a SIRT6 activator with an EC50 of 5 μM. SIRT6 activator 3 exhibits histone deacetylation activity. SIRT6 activator 3 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-183044
CAS No.: 1049800-47-6
Target:  

Sirtuin

Research Areas:  

Metabolic Disease

SIRT1 activator 4 is an orally active, NAD +-independent SIRT1 activator. SIRT1 activator 4 is also an analog of (E)-2'-desmethyl Sulindac (HY-B0008), with weak or negligible inhibitory activity against COX-1 and no inhibitory activity against COX-2. SIRT1 activator 4 can be used for the research of metabolic diseases .
loading...
    loading...